Kandiah, N., Pai, M., Senanarong, V., Looi, I., Ampil, E., Park, K. W., . . . Christopher, S. (2017). Rivastigmine: The advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia. Clin Interv Aging.

Kandiah, Nagaendran, Ming-Chyi Pai, Vorapun Senanarong, Irene Looi, Encarnita Ampil, Kyung Won Park, Ananda Krishna Karanam, and Stephen Christopher. "Rivastigmine: The Advantages of Dual Inhibition of Acetylcholinesterase and Butyrylcholinesterase and Its Role in Subcortical Vascular Dementia and Parkinson’s Disease Dementia." Clin Interv Aging 2017.

Kandiah, Nagaendran, et al. "Rivastigmine: The Advantages of Dual Inhibition of Acetylcholinesterase and Butyrylcholinesterase and Its Role in Subcortical Vascular Dementia and Parkinson’s Disease Dementia." Clin Interv Aging 2017.